Insulin efsitora alfa (investigational once-weekly basal insulin): In another ADA-sponsored symposium, Lilly will share results from the QWINT-1, QWINT-3 and QWINT-4 Phase 3 trials, which evaluated ...

On Wednesday night, the couple’s 27-year-old daughter, Savannah, shared the first footage of her dad following his release ...

Cortigent is developing the Stroke Recovery System to improve the recovery of arm and hand movement in people who have suffered paralysis due to stroke Spin-off will allow Vivani to focus on its ...

Tom Nolan reviews this week’s research Giving a hearing aid to people with untreated hearing loss helps them retain one additional person in their social network over a three year period. This catchy ...

Veru reports strong safety and efficacy for enobosarm added to semaglutide, showing reduced functional decline and muscle ...

76-year-old John Kane from Killiney, Dublin, remarked at his own experience with a drug similar to Ozempic and highlighted ...

View online. YOUR MORNINGMay 27, 2025 Good morning, NewsNation. For more fact-based, unbiased news coverage 24/7 – Download ...

Background: Canada has historically been among the world leaders in hypertension care, but hypertension treatment and control ...

The prospect of reducing the risk of some very common cancers adds the weight of evidence behind the GLP-1 agonist class, ...

India's healthtech space is expected to witness disruption as weight loss drugs Ozempic and Mounjaro enter the market through ...

Despite low obesity rates, Korea sees high demand for Wegovy, prompting misuse and regulatory concerns amid societal ...

Weight loss injections could be available in Northern Ireland on the health service, after the first regional obesity ...